Safety Assessment and Efficacy of Probiotic Bacillus clausii PBC429™ (MTCC 25459) for Management of Diarrhea
- 7 August 2025
- journal article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 18 (2) , 2491-2505
Abstract
In this study, we have evaluated the in vivo safety in rats and the efficacy of the probiotic strain Bacillus clausii (shouchella clausi) PBC429™ in mice for the treatment of diarrhea. In the acute toxicity study, a single oral dose of 2000 mg/kg (500 × 109 CFU/g) was administered to rats, followed by a sub-acute toxicity study for 28 days with repeated oral administration of Bacillus clausii PBC429™ at a dose of 250, 500, and 1000 mg/kg/day. In the present study, two doses of Bacillus clausii PBC429™ were tested in mice with castor oil-induced diarrhea. The results of this study indicate that no toxic effects of Bacillus clausii PBC429™ were observed at any dose administered for 28 days. No significant changes in body weight, clinical signs, hematological examinations, clinical biochemistry, gross pathology, or histopathology were observed between the control and test groups. Based on these results, NOAEL was found to be more than 2000 mg/kg and 1000 mg/kg (5 × 1011 CFU), respectively. Bacillus clausii PBC429™ reduced the frequency of defecation, onset of diarrhea, total fecal weight, and percentage of defecation. Thus, the results of this study suggest that Bacillus clausii is safe for human consumption and is an effective antidiarrheal agent.Keywords
This publication has 39 references indexed in Scilit:
- Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients—A Systematic Review and Meta-AnalysisAntibiotics, 2017
- RETRACTED: Repeated dose 28-day oral toxicity study of DEAE-Dextran in mice: An advancement in safety chemotherapeuticsRegulatory Toxicology and Pharmacology, 2017
- Safety assesment of Bacillus clausii UBBC07, a spore forming probioticToxicology Reports, 2017
- Bacillus clausii and gut homeostasis: state of the art and future perspectivesExpert Review of Gastroenterology & Hepatology, 2016
- Probiotic Bacillus cereus Strains, a Potential Risk for Public Health in ChinaFrontiers in Microbiology, 2016
- Acute and Sub-Acute Toxicity Evaluation of the Methanolic Extract of Alstonia scholaris Stem BarkMedical Sciences, 2016
- Synergistic impact of Lactobacillus fermentum, Lactobacillus plantarum and vincristine on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in miceExperimental and Therapeutic Medicine, 2012
- Safety assessment of probiotics for human useGut Microbes, 2010
- Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredientFood and Chemical Toxicology, 2009
- Probiotics for Prevention of Antibiotic-associated DiarrheaJournal of Clinical Gastroenterology, 2008